# Carlisle Companies Inc: Form 10-Q for the period ended Sep 30, 2022

- Company: [Carlisle Companies Inc](/companies/csl.md) (CIK 790051)
- Form: 10-Q
- Filed: 2022-10-28
- Accepted by EDGAR: Oct 28, 2022, 13:55 ET
- Period: 2022-09-30
- Accession: 0000790051-22-000190
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/790051/000079005122000190/csl-20220930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/790051/000079005122000190/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-01 to 2022-09-30 | $1.79bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $5.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-07-01 to 2022-09-30 | $1.20bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2022-01-01 to 2022-09-30 | $3.42bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2022-07-01 to 2022-09-30 | $13.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2022-01-01 to 2022-09-30 | $38.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2022-07-01 to 2022-09-30 | $209.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2022-01-01 to 2022-09-30 | $622.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | $348.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | $1.04bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-07-01 to 2022-09-30 | $22.6m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2022-01-01 to 2022-09-30 | $67.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-07-01 to 2022-09-30 | $72.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | $223.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | $254.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $749.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | $4.83 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $14.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | $4.90 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $14.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 52,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 52,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $588.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $130.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2022-01-01 to 2022-09-30 | $95.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2022-01-01 to 2022-09-30 | $201.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2022-09-30 | $2.77bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $7.73bn | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $1.55bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-09-30 | $2.28bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-09-30 | $651.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-09-30 | $3.04bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 55,523 characters.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a leading supplier of innovative building envelope products and energy-efficient solutions for customers creating sustainable buildings of the future. Through our Carlisle Construction Materials ("CCM") and Carlisle Weatherproofing Technologies ("CWT") businesses and family of leading brands, Carlisle delivers innovative, labor-reducing and environmentally responsible products and solutions to customers across the world through the Carlisle Experience. Over the life of a building, Carlisle’s products help drive lower greenhouse gas emissions, improve energy savings for building owners and operators, and increase a building’s resiliency to the elements. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior stockholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle also is a leading provider of products to the aerospace, medical technologies and general industrial markets through its Carlisle Interconnect Technologies ("CIT") and Carlisle Fluid Technologies ("CFT") business segments.

Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

### Executive Overview

In the third quarter, the Carlisle team continued to focus on delivering and enhancing the Carlisle Experience, which is our commitment to meeting the needs of our end users, distributors and contractors by providing industry-leading, energy-efficient solutions with the highest quality standards, to drive outstanding results. The performance delivered by the entire Carlisle team this quarter was especially remarkable given the macroeconomic environment, which has been a challenge for several years, and is becoming even more complicated with rising interest rates, high inflation and war in Europe. Despite another year of uncertainty and volatility in global markets, the Carlisle team came together to deliver on our commitments, leveraging strong underlying non-residential construction demand and mitigating market pressures to deliver a sixth consecutive quarter of record year-over-year sales and earnings performance in the midst of a global pandemic and recovery.

As we move into the fourth quarter, these results continue to demonstrate Carlisle's progress towards achieving our goals as laid out in Vision 2025, including delivering $15 of GAAP earnings per share.

U.S. non-residential construction demand remains strong, and we are optimistic that solid underlying trends will overcome recent and well-understood macroeconomic pressures. Additionally, pricing at all of our businesses continues to be positive, and improvements in supply chain and greater availability of materials are leading us toward a more normalized operating environment.

Residential markets are facing increased pressure due to interest rate hikes, significant inflation, and, at the consumer level, a reduction in building products expenditures. While impactful in the short term, we believe that longer term fundamentals in residential markets remain attractive given the undersupply of homes in the U.S. and growing demand for energy-efficient building solutions, particularly given recent supporting legislation and rising energy costs.

Aerospace markets continue their recovery, driving record backlogs and increased profitability in our CIT business on the back of restructuring actions taken over the past few years. We are very optimistic about the prospects for continued recovery in the aerospace markets, supported by a well-known shortage of aircraft, which has caused U.S. airlines to cut back on flights as they struggle to cope with the rebound in passenger demand.

In the first nine months of 2022, we used cash generated from operations to return $95.6 million to stockholders in the form of dividends and increased our dividend 39%, continuing our 46 year trend of continued and annually increasing dividends, and repurchased $201.1 million of shares, adding to our cumulative share repurchases since 2017 of over $2 billion. We invested $130.5 million into our businesses in the form of capital expenditures to drive innovation and the Carlisle Experience as exemplified by the third quarter launch of our industry-first 16' TPO line in Carlisle, PA.

The resilience and experience of the Carlisle team have helped us deliver record results throughout 2022 and will continue to provide Carlisle a competitive advantage as we navigate in this highly complex environment. We remain optimistic for the remainder of 2022, and are excited to continue our drive to exceed Carlisle's commitments under Vision 2025.

### Summary of Financial Results

*(in millions, except per share amounts)*

|  | Three Months Ended September 30, 2022 | 2021 | Nine Months Ended September 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenues | $1,794.1 | $1,315.6 | $5,137.3 | $3,434.3 |
| Operating income | $348.2 | $166.5 | $1,036.1 | $385.0 |
| Operating margin | 19.4% | 12.7% | 20.2% | 11.2% |
| Income from continuing operations | $255.2 | $113.0 | $745.4 | $256.2 |
| (Loss) income from discontinued operations | $(0.5) | $29.1 | $4.4 | $37.4 |
| Diluted earnings per share attributable to common shares: |  |  |  |  |
| Income from continuing operations | $4.84 | $2.12 | $14.12 | $4.80 |
| (Loss) income from discontinued operations | $(0.01) | $0.55 | $0.08 | $0.70 |
| Adjusted EBITDA(1) | $437.8 | $250.3 | $1,254.8 | $579.8 |
| Adjusted EBITDA margin(1) | 24.4% | 19.0% | 24.4% | 16.9% |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle's and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

Revenues increased in the third quarter and the first nine months of 2022 primarily reflecting positive pricing across all segments, contributions from the acquisition of ASP Henry Holdings, Inc. (“Henry”) in the CWT segment and higher sales volumes in the CCM and CIT segments, partially offset by unfavorable foreign currency impacts.

The increase in operating margin percentage in the third quarter and the first nine months of 2022 primarily reflected positive pricing, higher volumes and favorable product mix, partially offset by raw material and wage inflation across all segments.

Diluted earnings per share from continuing operations increased in the third quarter of 2022 primarily reflecting improved operating income performance ($2.60 per share), a lower effective tax rate ($0.09 per share) and reduced average shares outstanding ($0.04 per share).

Diluted earnings per share from continuing operations increased in the first nine months of 2022 primarily reflecting improved operating performance ($9.25 per share) and reduced average shares outstanding ($0.14 per share), partially offset by higher interest expense ($0.10 per share) and a higher effective tax rate ($0.03 per share).

We generated $588.6 million in operating cash flow in the first nine months of 2022 and utilized cash on hand and cash provided by operations to return capital to stockholders through dividends and share repurchases, and to fund capital expenditures.

### Consolidated Results of Operations

### Revenues

*(in millions)*

|  | 2022 | 2021 | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Three months ended September 30 | $1,794.1 | $1,315.6 | $478.5 | 36.4% | 9.2% | 28.3% | (1.1)% |
| Nine months ended September 30 | $5,137.3 | $3,434.3 | $1,703.0 | 49.6% | 12.9% | 37.6% | (0.9)% |

Revenues increased in the third quarter and the first nine months of 2022 primarily reflecting positive pricing across all segments, contributions from the acquisition of Henry in the CWT segment and higher sales volumes in the CCM and CIT segments, partially offset by unfavorable foreign currency impacts.

### Gross Margin

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross margin | $592.3 | $371.6 | $220.7 | 59.4% | $1,715.2 | $924.2 | $791.0 | 85.6% |
| Gross margin percentage | 33.0% | 28.2% |  |  | 33.4% | 26.9% |  |  |
| Depreciation and amortization | $26.1 | $26.4 |  |  | $78.5 | $75.1 |  |  |

Gross margin percentage (gross margin expressed as a percentage of revenues) increased in the third quarter and the first nine months of 2022, driven by positive pricing and higher volumes, partially offset by raw material and wage inflation. Also included in cost of goods sold were exit and disposal costs totaling $1.5 million and $4.4 million for the third quarter and the first nine months of 2022, respectively, primarily at CIT attributable to our restructuring initiatives, compared with $2.7 million and $7.1 million for the third quarter and the first nine months of 2021, respectively. Refer to Note 8 for further information on exit and disposal activities.

### Selling and Administrative Expenses

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling and administrative expenses | $209.0 | $192.6 | $16.4 | 8.5% | $622.6 | $504.7 | $117.9 | 23.4% |
| As a percentage of revenues | 11.6% | 14.6% |  |  | 12.1% | 14.7% |  |  |
| Depreciation and amortization | $36.4 | $30.7 |  |  | $110.0 | $79.9 |  |  |

The increase in selling and administrative expenses in the third quarter and the first nine months of 2022 primarily reflected incremental costs in the CWT segment from the addition of Henry, higher incentive compensation costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $0.4 million for the first nine months of 2022, primarily at CIT attributable to our restructuring initiatives, compared with $0.9 million and $4.3 million for the third quarter and the first nine months of 2021, respectively. Refer to Note 8 for further information on exit and disposal activities.

### Research and Development Expenses

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development expenses | $13.1 | $12.8 | $0.3 | 2.3% | $38.0 | $37.0 | $1.0 | 2.7% |
| As a percentage of revenues | 0.7% | 1.0% |  |  | 0.7% | 1.1% |  |  |
| Depreciation and amortization | $0.5 | $0.5 |  |  | $1.7 | $1.4 |  |  |

Research and development expenses were higher in the third quarter and the first nine months of 2022, primarily reflecting higher new product development expenses at our CWT and CFT segments.

### Other Operating Expense (Income), net

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| Other operating expense (income), net | $22.0 | $(0.3) | $22.3 | NM | $18.5 | $(2.5) | $21.0 | NM |

Other operating expense (income), net in the 2022 periods primarily reflected intangible asset impairments of $18.6 million and fixed asset impairments of $6.2 million in both the third quarter and first nine months at our CWT segment, partially offset by rebates ($1.0 million in the third quarter and $3.3 million in the first nine months), gains from insurance ($1.4 million in the third quarter and $1.1 million in the first nine months) and royalty income ($0.5 million in the third quarter and $1.4 million in the first nine months).

Other operating expense (income), net in the 2021 periods primarily reflected rebates ($0.9 million in third quarter and $2.6 million in the first nine months) and royalty income ($0.4 million in third quarter and $1.1 million in the first nine months), partially offset by intangible asset impairments of $1.8 million in both the third quarter and first nine months at CIT.

### Operating Income

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $348.2 | $166.5 | $181.7 | 109.1% | $1,036.1 | $385.0 | $651.1 | 169.1% |
| Operating margin percentage | 19.4% | 12.7% |  |  | 20.2% | 11.2% |  |  |

Refer to *Segment Results of Operations* within this MD&A for further information related to segment operating income results.

### Interest Expense, net

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense, net | $22.6 | $19.8 | $2.8 | 14.1% | $67.6 | $58.2 | $9.4 | 16.2% |

Interest expense, net of capitalized interest, increased in the third quarter and the first nine months of 2022 primarily reflecting higher long-term debt balances associated with our public offering of $550.0 million of 2.20% unsecured senior notes and $300.0 million of 0.55% unsecured senior notes completed in September 2021. Refer to Note 12 for further information on our long-term debt.

### Interest Income

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| Interest income | $(3.0) | $(0.2) | $(2.8) | NM | $(3.8) | $(1.1) | $(2.7) | NM |

Interest income increased during the third quarter and the first nine months of 2022 primarily reflecting higher yields and a higher invested cash balance.

### Other Non-operating Expense, net

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| Other non-operating expense, net | $1.2 | $0.9 | $0.3 | NM | $3.8 | $5.6 | $(1.8) | NM |

Other non-operating expense, net, in the third quarter and the first nine months of 2022 primarily reflected unrealized losses on Rabbi Trust investments and changes in foreign currencies against the U.S. Dollar.

Other non-operating expense, net in the first nine months of 2021 primarily reflected the release of a portion of the indemnification asset related to the Petersen Aluminum Corporation acquisition resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

### Income Taxes

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Provision for income taxes | $72.2 | $33.0 | $39.2 | 118.8% | $223.1 | $66.1 | $157.0 | 237.5% |
| Effective tax rate | 22.1% | 22.6% |  |  | 23.0% | 20.5% |  |  |

The effective income tax rate on continuing operations for the first nine months of 2022 was 23.0%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 23.8% and a tax impact of $7.4 million of discrete activity primarily related to excess tax benefits from employee stock compensation.

The effective income tax rate on continuing operations for the first nine months of 2021 was 20.5%.

### (Loss) Income from Discontinued Operations

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% | 2022 | Nine Months Ended September 30, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| (Loss) income from discontinued operations before income taxes | $(0.2) | $2.2 | $(2.4) | NM | $3.9 | $13.0 | $(9.1) | NM |
| Provision for (benefit from) income taxes | 0.3 | (26.9) |  |  | (0.5) | (24.4) |  |  |
| (Loss) income from discontinued operations | $(0.5) | $29.1 |  |  | $4.4 | $37.4 |  |  |

(Loss) income from discontinued operations in the first nine months of 2022 primarily reflects a gain on the sale of real estate associated with the 2021 sale of the equity interests and assets comprising the Carlisle Brake & Friction ("CBF") segment. Income from discontinued operations in the third quarter and the first nine months of 2021 reflects the operating results from the CBF segment. The 2021 periods also reflect a pre-tax loss on sale, offset by an income tax benefit from the sale transaction.

### Segment Results of Operations

### Carlisle Construction Materials

This segment produces a complete line of premium energy-efficient single-ply roofing products and warranted roof systems and accessories for the commercial building industry, including EPDM, TPO and PVC membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings.

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $1,090.3 | $783.9 | $306.4 | 39.1% | —% | 40.1% | (1.0)% |
| Operating income | $341.7 | $181.1 | $160.6 | 88.7% |  |  |  |
| Operating margin | 31.3% | 23.1% |  |  |  |  |  |
| Adjusted EBITDA(1) | $354.1 | $194.1 | $160.0 | 82.4% |  |  |  |
| Adjusted EBITDA margin(1) | 32.5% | 24.8% |  |  |  |  |  |

*(in millions)*

| 2022 | Nine Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $3,084.8 | $2,063.1 | $1,021.7 | 49.5% | —% | 50.3% | (0.8)% |
| Operating income | $961.7 | $446.8 | $514.9 | 115.2% |  |  |  |
| Operating margin | 31.2% | 21.7% |  |  |  |  |  |
| Adjusted EBITDA(1) | $1,000.7 | $486.3 | $514.4 | 105.8% |  |  |  |
| Adjusted EBITDA margin(1) | 32.4% | 23.6% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle's and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CCM’s revenue increased in the third quarter and the first nine months of 2022 primarily reflecting positive pricing across all product lines and the strength of U.S. commercial roofing demand.

CCM’s operating margin and adjusted EBITDA margin increase in the third quarter and the first nine months of 2022 primarily reflected positive pricing, higher volumes, and savings from Carlisle Operating System ("COS"), partially offset by raw material, freight and wage inflation.

### Carlisle Weatherproofing Technologies

This segment produces building envelope solutions that effectively drive energy efficiency and sustainability in commercial and residential applications. Products include high-performance waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers, sealants/primers and flashing systems, roof coatings and mastics, spray polyurethane foam and coating systems for a wide variety of thermal protection applications and other premium polyurethane products, block-molded expanded polystyrene insulation, engineered products for HVAC applications, and premium rubber products for a variety of industrial and surfacing applications.

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $406.7 | $281.9 | $124.8 | 44.3% | 42.7% | 2.2% | (0.6)% |
| Operating income | $9.6 | $6.0 | $3.6 | 60.0% |  |  |  |
| Operating margin | 2.4% | 2.1% |  |  |  |  |  |
| Adjusted EBITDA(1) | $59.1 | $46.4 | $12.7 | 27.4% |  |  |  |
| Adjusted EBITDA margin(1) | 14.5% | 16.5% |  |  |  |  |  |

*(in millions)*

| 2022 | Nine Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $1,214.7 | $659.3 | $555.4 | 84.2% | 66.9% | 17.7% | (0.4)% |
| Operating income | $106.1 | $39.0 | $67.1 | 172.1% |  |  |  |
| Operating margin | 8.7% | 5.9% |  |  |  |  |  |
| Adjusted EBITDA(1) | $205.7 | $100.2 | $105.5 | 105.3% |  |  |  |
| Adjusted EBITDA margin(1) | 16.9% | 15.2% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle's and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CWT’s revenue increased in the third quarter and the first nine months of 2022 primarily reflecting contributions from the Henry acquisition and positive pricing.

CWT’s operating margin increase in the third quarter and the first nine months of 2022 primarily reflected positive pricing and contributions from the Henry acquisition, partially offset by raw material, freight and wage inflation. The third quarter and the first nine months of 2022 also reflected intangible asset impairments of $18.6 million and fixed asset impairments of $6.2 million. The third quarter and the first nine months of 2021 reflect transaction related expenses of $22.3 million from the acquisition of Henry.

CWT’s adjusted EBITDA margin decrease in the third quarter of 2022 primarily reflected higher raw material, freight and labor costs and lower volumes, partially offset by favorable pricing and contributions from the Henry acquisition. CWT’s adjusted EBITDA margin increase in the first nine months of 2022 primarily reflected favorable pricing and contributions from the Henry acquisition, partially offset by higher raw material freight and labor costs and lower volumes.

### Carlisle Interconnect Technologies

This segment produces high-performance wire and cable, including optical fiber, for the commercial aerospace, military and defense electronics, medical device, industrial, and test and measurement markets. CIT's product portfolio also includes sensors, connectors, contacts, cable assemblies, complex harnesses, racks, trays, and installation kits, in addition to engineering and certification services. CIT also provides medical device products and solutions for several medical technology applications.

During the third quarter of 2021, we announced the closure of our manufacturing operations in Carlsbad, California, and the relocation of those operations to our existing facilities in North America. The project is estimated to take a remaining three to six months to complete. Total projected costs are expected to approximate $7.0 million, with approximately $2.8 million costs remaining to be incurred.

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $223.7 | $178.7 | $45.0 | 25.2% | —% | 25.5% | (0.3)% |
| Operating income (loss) | $12.9 | $(0.5) | $13.4 | NM |  |  |  |
| Operating margin | 5.8% | (0.3)% |  |  |  |  |  |
| Adjusted EBITDA(1) | $33.3 | $23.2 | $10.1 | 43.5% |  |  |  |
| Adjusted EBITDA margin(1) | 14.9% | 13.0% |  |  |  |  |  |

*(in millions)*

| 2022 | Nine Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $621.3 | $503.4 | $117.9 | 23.4% | —% | 23.5% | (0.1)% |
| Operating income (loss) | $18.3 | $(24.1) | $42.4 | NM |  |  |  |
| Operating margin | 2.9% | (4.8)% |  |  |  |  |  |
| Adjusted EBITDA(1) | $78.7 | $47.7 | $31.0 | 65.0% |  |  |  |
| Adjusted EBITDA margin(1) | 12.7% | 9.5% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle's and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CIT’s revenue increase in the third quarter and the first nine months of 2022 primarily reflected continued strengthening of aerospace and medical end markets.

CIT’s operating margin and adjusted EBITDA margin increase in the third quarter and the first nine months of 2022 primarily reflected higher volumes, positive pricing, and savings from COS, partially offset by raw material and wage inflation, unfavorable product mix and higher operating expenses.

### Carlisle Fluid Technologies

This segment produces highly engineered liquid, powder, sealants and adhesives finishing equipment and integrated system solutions for spraying, pumping, mixing, metering and curing of a variety of coatings used in the automotive manufacture, general industrial, protective coating, wood, specialty and automotive refinishing markets.

*(in millions)*

| 2022 | Three Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $73.4 | $71.1 | $2.3 | 3.2% | —% | 10.1% | (6.9)% |
| Operating income | $11.7 | $4.7 | $7.0 | 148.9% |  |  |  |
| Operating margin | 15.9% | 6.6% |  |  |  |  |  |
| Adjusted EBITDA(1) | $15.8 | $10.9 | $4.9 | 45.0% |  |  |  |
| Adjusted EBITDA margin(1) | 21.5% | 15.3% |  |  |  |  |  |

*(in millions)*

| 2022 | Nine Months Ended September 30, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $216.5 | $208.5 | $8.0 | 3.8% | —% | 8.4% | (4.6)% |
| Operating income | $23.5 | $15.6 | $7.9 | 50.6% |  |  |  |
| Operating margin | 10.9% | 7.5% |  |  |  |  |  |
| Adjusted EBITDA(1) | $38.5 | $32.5 | $6.0 | 18.5% |  |  |  |
| Adjusted EBITDA margin(1) | 17.8% | 15.6% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle's and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CFT’s revenue increase in the third quarter and the first nine months of 2022 primarily reflected positive pricing, partially offset by unfavorable changes in foreign currency rates.

CFT’s operating margin and adjusted EBITDA margin increase in the third quarter and the first nine months of 2022 primarily reflected positive pricing and savings from COS, partially offset by raw material, freight and wage inflation.

### Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

*(in millions)*

|  | September 30, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Europe | $79.2 | $12.3 |
| North America (excluding U.S.) | 40.9 | 40.8 |
| China | 15.1 | 17.8 |
| Asia Pacific (excluding China) | 17.5 | 12.9 |
| International cash and cash equivalents | 152.7 | 83.8 |
| U.S. cash and cash equivalents | 472.7 | 240.6 |
| Total cash and cash equivalents | $625.4 | $324.4 |

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under the Company's Fourth Amended and Restated Credit Agreement (as amended, the "Facility"). In the near term, cash on hand is our primary source of liquidity. The increase in cash and cash equivalents compared to December 31, 2021, is primarily related to cash generated from operations and the receipt of the $125 million earn out payment from the sale of CBF, partially offset by share repurchases, capital expenditures and payment of dividends to stockholders.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in Canada and China, we may be subject to withholding taxes, and as such we have accrued $7.6 million in anticipation of those taxes as of September 30, 2022.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated long-term business requirements and to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets for a variety of reasons, including to repay the outstanding balances of our outstanding debt and fund acquisitions. Refer to Note 12.

### Sources and Uses of Cash and Cash Equivalents

*(in millions)*

|  | Nine Months Ended September 30, 2022 | 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $588.6 | $283.9 |
| Net cash used in investing activities | (10.7) | (1,423.2) |
| Net cash (used in) provided by financing activities | (273.2) | 533.9 |
| Effect of foreign currency exchange rate changes on cash | (3.7) | (1.2) |
| Change in cash and cash equivalents | $301.0 | $(606.6) |

#### Operating Activities

We generated operating cash flows of $588.6 million for the first nine months of 2022 (including working capital uses of $416.0 million), compared with $283.9 million for the first nine months of 2021 (including working capital uses of $208.2 million). Higher operating cash flows for the first nine months of 2022 primarily reflected higher net income, partially offset by higher working capital uses related to an increase in inventory from rising raw material costs and increased volume and an increase in receivables from higher sales.

#### Investing Activities

Cash used in investing activities of $10.7 million for the first nine months of 2022 primarily reflected capital expenditures of $130.5 million and the acquisition of MBTechnology for $24.7 million, partially offset by the proceeds of the contingent consideration from the earn out payment and sale of real estate associated with the 2021 sale of CBF of $132.0 million and proceeds from investment in securities of $10.3 million. Cash used in investing activities of $1,423.2 million for the first nine months of 2021 primarily reflected the acquisition of Henry for $1,573.9 million, net of cash acquired, capital expenditures of $88.9 million and investment in securities of $10.2 million, partially offset by proceeds from the sale of CBF of $247.7 million, net of cash disposed.

#### Financing Activities

Cash used in financing activities of $273.2 million in the first nine months of 2022 primarily reflected share repurchases of $201.1 million and cash dividend payments of $95.6 million, reflecting the increased quarterly dividend of $0.75 per share. Cash provided by financing activities of $533.9 million during the first nine months of 2021 primarily reflected net proceeds from our September 2021 offering of $850.0 million in aggregate principal amount of unsecured senior notes, partially offset by share repurchases of $290.6 million and cash dividend payments of $84.2 million.

### Debt Instruments

#### Senior Notes

On September 14, 2022, we issued a notice for the redemption in full of our outstanding $350.0 million aggregate principal amount unsecured senior notes due November 15, 2022 (the "2022 Notes"). The 2022 Notes were redeemed on October 17, 2022, at the redemption price of $355.5 million, including $5.5 million of interest to the redemption date.

#### Revolving Credit Facility

During the first nine months of 2022, we had no borrowings or repayments under the Facility. During the first nine months of 2021, borrowings and repayments under the Facility totaled $650.0 million with a weighted average interest rate of 1.125%. As of September 30, 2022 and December 31, 2021, the Facility had no outstanding balance and $1.0 billion available for use.

#### Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of September 30, 2022 and December 31, 2021.

Refer to Note 12 for further information on our debt instruments.

### Critical Accounting Estimates

Our significant accounting policies are more fully described in Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2021. In preparing the Consolidated Financial Statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), the Company’s management must make informed decisions which impact the reported amounts and related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions on which to base estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates, including those related to goodwill and indefinite-lived intangible assets, valuation of long-lived assets, revenue recognition, income taxes and extended product warranties on an ongoing basis. The Company bases its estimates on historical experience, terms of existing contracts, our observation of trends in the industry, information provided by our customers and information available from other outside sources, that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amount of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

### Subsequent Measurement of Goodwill

Goodwill is not amortized but is tested annually, or more often if impairment indicators are present, for impairment at a reporting unit level, Goodwill is tested for impairment via a one-step process by comparing the fair value of goodwill with its carrying value. We recognize an impairment for the amount by which the carrying amount exceeds the fair value. We estimate the fair value of our reporting units based on the income approach utilizing the discounted cash flow method and the market approach utilizing the public company market multiple method. The key techniques and assumptions used include:

| Valuation Technique | Key Assumptions |
| --- | --- |
| Discounted future cash flows | •Estimated future revenues •Earnings before interest, taxes, depreciation and amortization ("EBITDA") margins •Discount rates |
| Market multiple method | •Peer public company group •Financial performance of reporting units relative to peer public company group |

In the third quarter of 2022, changes in macroeconomic facts and circumstances, particularly high inflation and the resulting rise in interest rates, has resulted in reduced expectations of fair value. We considered these circumstances and the potential long-term impact on our reporting units and determined that an indicator of possible impairment existed within our CIT Medical reporting unit. Accordingly, we performed a quantitative impairment analysis to determine the fair value of this reporting unit as of September 30, 2022, resulting in a fair value that exceeded the carrying amount by approximately 10 percent. Accordingly, no impairment charge was recorded. The carrying amount of goodwill for the CIT Medical reporting unit was $233.9 million as of September 30, 2022.

We will continue to closely monitor actual results versus expectations as well as whether and to what extent any significant changes in current events or conditions result in corresponding changes to our expectations about future estimated cash flows, discount rates and market multiples. If our adjusted expectations of the operating results, both in size and timing, of CIT Medical do not materialize, if the discount rate increases (based on increases in interest rates, market rates of return or market volatility) or if market multiples decline, we may be required to record goodwill impairment charges, which may be material.

While we believe our conclusions regarding the estimates of fair value of our reporting units are appropriate, these estimates are subject to uncertainty and by nature include judgments and estimates regarding various factors. These factors include the rate and extent of growth in the markets that our reporting units serve, the realization of future sales price and volume increases, fluctuations in exchange rates, fluctuations in price and availability of key raw materials, future operating efficiencies and, as it pertains to discount rates, the volatility in interest rates and costs of equity.

### Subsequent Measurement of Long-Lived Assets

Long-lived assets or asset groups, including amortizable intangible assets, are tested for recoverability whenever events or circumstances indicate that the undiscounted future cash flows do not exceed the carrying amount of the asset or asset group. For purposes of testing for impairment, we group our long-lived assets classified as held and used at the lowest level for which identifiable cash flows are largely independent of the cash flows from other assets and liabilities, which means that in many cases multiple assets are tested for recovery as a group. Our asset groupings vary based on the related business in which the long-lived assets are employed and the interrelationship between those long-lived assets in producing net cash flows; for example, multiple manufacturing facilities may work in concert with one another or may work on a stand-alone basis to produce net cash flows. We utilize our long-lived assets in multiple industries and economic environments, and our asset groupings reflect these various factors.

We monitor the operating and cash flow results of our long-lived assets or asset groups classified as held and used to identify whether events and circumstances indicate the remaining useful lives of those assets should be adjusted, or if the carrying value of those assets or asset groups may not be recoverable. Undiscounted estimated future cash flows are compared to the carrying value of the long-lived asset or asset group in the event indicators of impairment are identified. In developing our estimates of future undiscounted cash flows, we utilize our internal estimates of future revenues, costs and other net cash flows from operating and disposing the long-lived asset or asset group over the life of the asset or primary asset, if an asset group. This requires us to make judgments about future levels of sales volume, pricing, raw material costs and other operating expenses.

If the undiscounted estimated future cash flows are less than the carrying amount, we determine the fair value of the asset or asset group and record an impairment charge in current earnings to the extent carrying value exceeds fair value. Fair values may be determined based on estimated discounted cash flows, by prices for like or similar assets in similar markets or a combination of both.

In the third quarter of 2022, the current and projected operating and cash flow losses at our rubber asset group within the CWT operating segment resulted in the determination that an indicator of impairment existed. Accordingly, we performed a quantitative impairment analysis to determine whether the carrying value of the asset group was recoverable, and if not, determine the fair value of the asset group using the methods described above.

Based on the analysis, we determined that the undiscounted cash flows for the asset group did not exceed its carrying value. In determining the asset group's fair value, we utilized a market approach of assessing the exit prices for like or similar assets in similar markets and potential exit prices willing to be paid for the asset group by a market participant in an open market. Based on this assessment, we determined that the asset group's carrying value exceeded its fair value as of September 30, 2022, resulting in an impairment of property, plant, and equipment and definite-lived intangible assets of $6.2 million and $18.6 million, respectively.

We will continue to closely monitor whether and to what extent any significant changes in current events or conditions may result in corresponding changes to our expectation on the market value of the collective asset group. If our expectation of a market exit price willing to be paid by a market participant for the collective asset group does not materialize or changes due to known market conditions, we may be required to record additional impairments to the asset group, which may be material.

### Non-GAAP Financial Measures

### EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about our performance and our segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in our business and evaluate our performance relative to similarly-situated companies. This information differs from net income, operating income, and operating margin determined in accordance with GAAP and should not be considered in isolation or as a substitute for measures of performance determined in accordance with GAAP. Our and our segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

*(in millions)*

|  | Three Months Ended September 30, 2022 | 2021 | Nine Months Ended September 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| Net income (GAAP) | $254.7 | $142.1 | $749.8 | $293.6 |
| Less: (loss) income from discontinued operations (GAAP) | (0.5) | 29.1 | 4.4 | 37.4 |
| Income from continuing operations (GAAP) | 255.2 | 113.0 | 745.4 | 256.2 |
| Provision for income taxes | 72.2 | 33.0 | 223.1 | 66.1 |
| Interest expense, net | 22.6 | 19.8 | 67.6 | 58.2 |
| Interest income | (3.0) | (0.2) | (3.8) | (1.1) |
| EBIT | 347.0 | 165.6 | 1,032.3 | 379.4 |
| Exit and disposal, and facility rationalization costs | 1.4 | 3.4 | 4.2 | 14.0 |
| Inventory step-up amortization and transaction costs | 2.4 | 22.2 | 3.2 | 24.4 |
| Impairment charges | 25.1 | 1.8 | 25.3 | 1.8 |
| Losses from acquisitions and disposals | 0.3 | — | 0.7 | 3.5 |
| (Gains) losses from insurance | (1.4) | (0.3) | (1.1) | 0.2 |
| Losses from litigation | — | — | — | 0.1 |
| Total non-comparable items | 27.8 | 27.1 | 32.3 | 44.0 |
| Adjusted EBIT | 374.8 | 192.7 | 1,064.6 | 423.4 |
| Depreciation | 24.7 | 21.6 | 72.7 | 62.2 |
| Amortization | 38.3 | 36.0 | 117.5 | 94.2 |
| Adjusted EBITDA | $437.8 | $250.3 | $1,254.8 | $579.8 |
| Divided by: |  |  |  |  |
| Total revenues | $1,794.1 | $1,315.6 | $5,137.3 | $3,434.3 |
| Adjusted EBITDA margin | 24.4% | 19.0% | 24.4% | 16.9% |

33

*(in millions)*

|  | Three Months Ended September 30, 2022 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $341.7 | $9.6 | $12.9 | $11.7 | $(27.7) |
| Non-operating expense (income)(1) | 1.2 | 0.2 | (0.8) | (0.4) | 1.0 |
| EBIT | 340.5 | 9.4 | 13.7 | 12.1 | (28.7) |
| Exit and disposal, and facility rationalization costs | — | — | 1.4 | — | — |
| Inventory step-up amortization and transaction costs | — | — | — | 0.1 | 2.3 |
| Impairment charges | — | 24.8 | — | — | 0.3 |
| Losses (gains) from acquisitions and disposals | — | 0.2 | 0.1 | — | — |
| Gains from insurance | — | — | — | (1.4) | — |
| Total non-comparable items | — | 25.0 | 1.5 | (1.3) | 2.6 |
| Adjusted EBIT | 340.5 | 34.4 | 15.2 | 10.8 | (26.1) |
| Depreciation | 9.8 | 6.4 | 6.1 | 1.4 | 1.0 |
| Amortization | 3.8 | 18.3 | 12.0 | 3.6 | 0.6 |
| Adjusted EBITDA | $354.1 | $59.1 | $33.3 | $15.8 | $(24.5) |
| Divided by: |  |  |  |  |  |
| Total revenues | $1,090.3 | $406.7 | $223.7 | $73.4 | $— |
| Adjusted EBITDA margin | 32.5% | 14.5% | 14.9% | 21.5% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

*(in millions)*

|  | Three Months Ended September 30, 2021 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $181.1 | $6.0 | $(0.5) | $4.7 | $(24.8) |
| Non-operating expense (income)(1) | 0.3 | 0.1 | (0.1) | (0.2) | 0.8 |
| EBIT | 180.8 | 5.9 | (0.4) | 4.9 | (25.6) |
| Exit and disposal, and facility rationalization costs | 0.1 | — | 2.8 | 0.5 | — |
| Inventory step-up amortization and transaction costs | — | 22.3 | — | — | (0.1) |
| Impairment charges | — | — | 1.8 | — | — |
| (Gains) losses from acquisitions and disposals | (0.1) | 0.1 | — | — | — |
| Gains from insurance | — | — | — | (0.3) | — |
| Losses (gains) from litigation | — | — | 0.1 | — | (0.1) |
| Total non-comparable items | — | 22.4 | 4.7 | 0.2 | (0.2) |
| Adjusted EBIT | 180.8 | 28.3 | 4.3 | 5.1 | (25.8) |
| Depreciation | 9.1 | 3.8 | 6.3 | 1.4 | 1.0 |
| Amortization | 4.2 | 14.3 | 12.6 | 4.4 | 0.5 |
| Adjusted EBITDA | $194.1 | $46.4 | $23.2 | $10.9 | $(24.3) |
| Divided by: |  |  |  |  |  |
| Total revenues | $783.9 | $281.9 | $178.7 | $71.1 | $— |
| Adjusted EBITDA margin | 24.8% | 16.5% | 13.0% | 15.3% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

*(in millions)*

|  | Nine Months Ended September 30, 2022 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $961.7 | $106.1 | $18.3 | $23.5 | $(73.5) |
| Non-operating expense (income)(1) | 2.1 | 0.4 | (1.6) | (0.3) | 3.2 |
| EBIT | 959.6 | 105.7 | 19.9 | 23.8 | (76.7) |
| Exit and disposal, and facility rationalization costs | — | 0.1 | 4.1 | — | — |
| Inventory step-up amortization and transaction costs | — | — | — | 0.1 | 3.1 |
| Impairment charges | — | 25.0 | — | — | 0.3 |
| (Gains) losses from acquisitions and disposals | (0.1) | 0.2 | 0.5 | 0.1 | — |
| Losses (gains) from insurance | — | 0.3 | — | (1.4) | — |
| (Gains) losses from litigation | — | — | (0.1) | — | 0.1 |
| Total non-comparable items | (0.1) | 25.6 | 4.5 | (1.2) | 3.5 |
| Adjusted EBIT | 959.5 | 131.3 | 24.4 | 22.6 | (73.2) |
| Depreciation | 28.3 | 19.1 | 18.3 | 4.3 | 2.7 |
| Amortization | 12.9 | 55.3 | 36.0 | 11.6 | 1.7 |
| Adjusted EBITDA | $1,000.7 | $205.7 | $78.7 | $38.5 | $(68.8) |
| Divided by: |  |  |  |  |  |
| Total revenues | $3,084.8 | $1,214.7 | $621.3 | $216.5 | $— |
| Adjusted EBITDA margin | 32.4% | 16.9% | 12.7% | 17.8% | NM |

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

*(in millions)*

|  | Nine Months Ended September 30, 2021 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $446.8 | $39.0 | $(24.1) | $15.6 | $(92.3) |
| Non-operating expense (income)(1) | 2.6 | 0.1 | (0.1) | 1.3 | 1.7 |
| EBIT | 444.2 | 38.9 | (24.0) | 14.3 | (94.0) |
| Exit and disposal, and facility rationalization costs | 0.1 | — | 13.0 | 0.9 | — |
| Inventory step-up amortization and transaction costs | — | 22.3 | — | 0.1 | 2.0 |
| Impairment charges | — | — | 1.8 | — | — |
| Losses from acquisitions and disposals | 2.1 | 0.1 | 0.3 | 0.2 | 0.8 |
| Losses (gains) from insurance | 0.3 | 0.2 | — | (0.3) | — |
| Losses from litigation | — | — | 0.1 | — | — |
| Total non-comparable items | 2.5 | 22.6 | 15.2 | 0.9 | 2.8 |
| Adjusted EBIT | 446.7 | 61.5 | (8.8) | 15.2 | (91.2) |
| Depreciation | 27.4 | 9.4 | 18.6 | 4.0 | 2.8 |
| Amortization | 12.2 | 29.3 | 37.9 | 13.3 | 1.5 |
| Adjusted EBITDA | $486.3 | $100.2 | $47.7 | $32.5 | $(86.9) |
| Divided by: |  |  |  |  |  |
| Total revenues | $2,063.1 | $659.3 | $503.4 | $208.5 | $— |
| Adjusted EBITDA margin | 23.6% | 15.2% | 9.5% | 15.6% | NM |

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

### Outlook

Our expectations for segment and total revenues for 2022, compared to 2021 follow:

|  | 2022 Revenue | Primary Drivers |
| --- | --- | --- |
| Carlisle Construction Materials | 35 to 40% growth | •Strong re-roofing and new construction activity •Pricing to the value of the Carlisle Experience •Increasing demand for energy-efficient building products |
| Carlisle Weatherproofing Technologies | Approximately 60% growth | •Henry acquisition •Non-residential demand growth within our channels |
| Carlisle Interconnect Technologies | Exceed 20% growth | •Growing demand in commercial aerospace and medical markets •Backlog growing |
| Carlisle Fluid Technologies | Mid single-digit growth | •Focus on new product introductions and price discipline •Backlog growing |
| Total Carlisle | 35 to 40% growth |  |

For the year 2022, we expect:

- Corporate expenses of approximately $105 million;
- Depreciation and amortization expense of approximately $250 million;
- Capital expenditures of approximately $175 million;
- Interest expense, net of interest income, of approximately $90 million; and
- Base tax rate of approximately 24-25%.

### Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of the COVID-19 pandemic on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs that cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions; our successful completion of strategic dispositions; the cyclical nature of our businesses; the impact of information technology, cybersecurity or data security breaches at our businesses or third parties; the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions, including inflation and interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena, including the Russian invasion of Ukraine, may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

## Market risk

As filed, 275 characters.

There have been no material changes in the Company’s market risk for the nine months ended September 30, 2022. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2021 Annual Report on Form 10-K.

## Controls and procedures

As filed, 1,717 characters.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of September 30, 2022, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During third quarter of 2021, the Company completed its acquisition of ASP Henry Holdings, Inc. (“Henry”). This acquisition is material to the Company's results of operations, financial position and cash flows. Refer to Note 3 for additional information regarding the Henry acquisition.

The Company is currently in the process of integrating Henry, including internal controls and procedures and extending its Sarbanes-Oxley Act Section 404 compliance program to include Henry. The Company anticipates a successful integration of Henry's operations and internal controls and procedures and will continue to evaluate its internal control over financial reporting as the Company executes integration activities. The Company's assessment of the effectiveness of controls and procedures for the year ended December 31, 2022, will include Henry.

During the first nine months of months of 2022, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 149 characters.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2021 Annual Report on Form 10-K.

Filed Oct 28, 2022.
Source: SEC EDGAR, the filing index for accession 0000790051-22-000190. Last ingested by Listed: Nov 10, 2026, 16:42 ET. No prices; not investment advice.
